148 related articles for article (PubMed ID: 10767567)
41. Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use.
Amnuaikit C; Ikeuchi I; Ogawara K; Higaki K; Kimura T
Int J Pharm; 2005 Jan; 289(1-2):167-78. PubMed ID: 15652209
[TBL] [Abstract][Full Text] [Related]
42. The effects of terpenes on the permeation of lidocaine and ofloxacin from moisture-activated patches.
Song YH; Gwak HS; Chun IK
Drug Deliv; 2009 Feb; 16(2):75-81. PubMed ID: 19267298
[TBL] [Abstract][Full Text] [Related]
43. Observation of swelling process and diffusion front position during swelling in hydroxypropyl methyl cellulose (HPMC) matrices containing a soluble drug.
Colombo P; Bettini R; Peppas NA
J Control Release; 1999 Aug; 61(1-2):83-91. PubMed ID: 10469905
[TBL] [Abstract][Full Text] [Related]
44. Synthesis and evaluation of N-acetylprolinate esters - novel skin penetration enhancers.
Tenjarla SN; Kasina R; Puranajoti P; Omar MS; Harris WT
Int J Pharm; 1999 Dec; 192(2):147-58. PubMed ID: 10567746
[TBL] [Abstract][Full Text] [Related]
45. Transdermal delivery of highly lipophilic drugs: in vitro fluxes of antiestrogens, permeation enhancers, and solvents from liquid formulations.
Funke AP; Schiller R; Motzkus HW; Günther C; Müller RH; Lipp R
Pharm Res; 2002 May; 19(5):661-8. PubMed ID: 12069170
[TBL] [Abstract][Full Text] [Related]
46. Penetration enhancement of ibuprofen from supersaturated solutions through human skin.
Iervolino M; Cappello B; Raghavan SL; Hadgraft J
Int J Pharm; 2001 Jan; 212(1):131-41. PubMed ID: 11165828
[TBL] [Abstract][Full Text] [Related]
47. Formulation development of transdermal dosage forms: quantitative structure-activity relationship model for predicting activities of terpenes that enhance drug penetration through human skin.
Kang L; Yap CW; Lim PF; Chen YZ; Ho PC; Chan YW; Wong GP; Chan SY
J Control Release; 2007 Jul; 120(3):211-9. PubMed ID: 17582639
[TBL] [Abstract][Full Text] [Related]
48. Enhanced penetration of mitomycin C through hairless mouse and rat skin by enhancers with terpene moieties.
Okamoto H; Ohyabu M; Hashida M; Sezaki H
J Pharm Pharmacol; 1987 Jul; 39(7):531-4. PubMed ID: 2886622
[TBL] [Abstract][Full Text] [Related]
49. Some general influences of n-decylmethyl sulfoxide on the permeation of drugs across hairless mouse skin.
Choi HK; Amidon GL; Flynn GL
J Invest Dermatol; 1991 Jun; 96(6):822-6. PubMed ID: 2045670
[TBL] [Abstract][Full Text] [Related]
50. Estimation of transdermal permeation parameters in non-stationary diffusion experiments. Application to pre-treatment studies with terpenes.
Boix A; Peraire C; Obach R; Domenech J
Pharm Res; 2005 Jan; 22(1):94-102. PubMed ID: 15771235
[TBL] [Abstract][Full Text] [Related]
51. In vivo evaluation of limonene-based transdermal therapeutic system of nicorandil in healthy human volunteers.
Krishnaiah YS; Chandrasekhar DV; Rama B; Jayaram B; Satyanarayana V; Al-Saidan SM
Skin Pharmacol Physiol; 2005; 18(6):263-72. PubMed ID: 16113596
[TBL] [Abstract][Full Text] [Related]
52. Basil oil is a promising skin penetration enhancer for transdermal delivery of labetolol hydrochloride.
Jain R; Aqil M; Ahad A; Ali A; Khar RK
Drug Dev Ind Pharm; 2008 Apr; 34(4):384-9. PubMed ID: 18401780
[TBL] [Abstract][Full Text] [Related]
53. Evaluation of transdermal penetration enhancers using a novel skin alternative.
Godwin DA; Michniak BB; Creek KE
J Pharm Sci; 1997 Sep; 86(9):1001-5. PubMed ID: 9294812
[TBL] [Abstract][Full Text] [Related]
54. Effect of nerodilol, carvone and anethole on the in vitro transdermal delivery of selegiline hydrochloride.
Krishnaiah YS; Al-Saidan SM; Jayaram B
Pharmazie; 2006 Jan; 61(1):46-53. PubMed ID: 16454206
[TBL] [Abstract][Full Text] [Related]
55. In vitro and ex vivo permeation studies of etodolac from hydrophilic gels and effect of terpenes as enhancers.
Tas C; Ozkan Y; Okyar A; Savaser A
Drug Deliv; 2007 Oct; 14(7):453-9. PubMed ID: 17994363
[TBL] [Abstract][Full Text] [Related]
56. Wide-angle X-ray diffraction of human stratum corneum: effects of hydration and terpene enhancer treatment.
Cornwell PA; Barry BW; Stoddart CP; Bouwstra JA
J Pharm Pharmacol; 1994 Dec; 46(12):938-50. PubMed ID: 7536240
[TBL] [Abstract][Full Text] [Related]
57. Membrane penetration enhancement of ibuprofen using supersaturation.
Iervolino M; Raghavan SL; Hadgraft J
Int J Pharm; 2000 Apr; 198(2):229-38. PubMed ID: 10767571
[TBL] [Abstract][Full Text] [Related]
58. Esters of terpene alcohols as highly potent, reversible, and low toxic skin penetration enhancers.
Kopečná M; Macháček M; Nováčková A; Paraskevopoulos G; Roh J; Vávrová K
Sci Rep; 2019 Oct; 9(1):14617. PubMed ID: 31601936
[TBL] [Abstract][Full Text] [Related]
59. Cutaneous biotransformation of N-(4-bromobenzoyl)-S,S-dimethyliminosulfurane and its product, 4-bromobenzamide, leading to percutaneous penetration enhancement of drugs: initial evidence using hydrocortisone.
Sintov AC; Zhang PJ; Michniak-Kohn BB
J Control Release; 2009 Jan; 133(1):44-51. PubMed ID: 18950667
[TBL] [Abstract][Full Text] [Related]
60. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies.
Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A
Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
